Xagenic Inc. — Form D

Xagenic Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-12. The offering totals $21.3M, of which $9.6M was reported sold. Industry: Biotechnology.

Offering

Filed: 2013-12-12
Form: D
Accession: 0001594154-13-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $21.3M
Amount sold: $9.6M
Remaining: $11.7M
Investors: 6
Date of first sale: 2013-11-26
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-207891

Issuer

Name: Xagenic Inc.
CIK: 0001594154
Entity type: Corporation
Jurisdiction: ONTARIO, CANADA
Incorporated: 2010
Address: 55 YORK STREET, SUITE 1600, TORONTO, A6, M5J 1R7
Phone: (416) 363-1999

Officers, directors & promoters (10)

Name	Role	Location
Bruce A Cohen	Director	Toronto, A6
Erik A Holmlin, Ph.D., M.B.A.	Director	Toronto, A6
Shana Kelley, Ph.D.	Director	Toronto, A6
Shermaine A Tilley, Ph.D., M.B.A.	Director	Toronto, A6
Jesse A Treu, Ph.D.	Director	Toronto, A6
Ihor A Boszko	Executive Officer	Toronto, A6
Bruce A Cohen	Executive Officer	Toronto, A6
Jack D Graham	Executive Officer	Toronto, A6
Shana Kelley, Ph.D.	Executive Officer	Toronto, A6
Yuri D Kuzyk	Executive Officer	Toronto, A6

More